471 filings
Page 6 of 24
4
MYMD
MyMD Pharmaceuticals Inc
15 Oct 21
MyMD Pharmaceuticals / Jude Uzonwanne ownership change
5:21pm
4
Craig Eagle
15 Oct 21
MyMD Pharmaceuticals / CRAIG EAGLE ownership change
5:21pm
4
Silverman Joshua
15 Oct 21
MyMD Pharmaceuticals / Joshua Silverman ownership change
5:20pm
4
Christopher C Chapman JR
15 Oct 21
MyMD Pharmaceuticals / Christopher C Chapman JR ownership change
5:20pm
4
Paul Rivard
15 Oct 21
MyMD Pharmaceuticals / Paul Rivard ownership change
5:20pm
8-K
MYMD
MyMD Pharmaceuticals Inc
5 Oct 21
MyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials
10:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
22 Sep 21
MyMD Pharmaceuticals Announces New Data Demonstrating 8,000
12:52pm
8-K
MYMD
MyMD Pharmaceuticals Inc
13 Sep 21
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
5:30pm
8-K
MYMD
MyMD Pharmaceuticals Inc
3 Sep 21
Departure of Directors or Certain Officers
4:38pm
10-Q
2021 Q2
MYMD
MyMD Pharmaceuticals Inc
Quarterly report
16 Aug 21
4:14pm
8-K
MYMD
MyMD Pharmaceuticals Inc
2 Jul 21
Departure of Directors or Certain Officers
5:00pm
8-K/A
MYMD
MyMD Pharmaceuticals Inc
2 Jul 21
Financial Statements and Exhibits
4:00pm
10-Q
2021 Q1
MYMD
MyMD Pharmaceuticals Inc
Quarterly report
18 May 21
6:10am
NT 10-Q
MYMD
MyMD Pharmaceuticals Inc
18 May 21
Notice of late quarterly filing
6:04am
8-K
MYMD
MyMD Pharmaceuticals Inc
13 May 21
Regulation FD Disclosure
6:20am
EFFECT
MYMD
MyMD Pharmaceuticals Inc
12 May 21
Notice of effectiveness
12:15am
424B3
MYMD
MyMD Pharmaceuticals Inc
11 May 21
Prospectus supplement
4:27pm
CORRESP
MYMD
MyMD Pharmaceuticals Inc
10 May 21
Correspondence with SEC
12:00am
S-3/A
MYMD
MyMD Pharmaceuticals Inc
Shelf registration (amended)
28 Apr 21
5:25pm
CORRESP
MYMD
MyMD Pharmaceuticals Inc
28 Apr 21
Correspondence with SEC
12:00am